Pharmafile Logo
Pharmafocus logo
Advanced Search

Shire

Showing 5 posts of 170 posts found.

Shire

Shire files for Gaucher drug in Europe

December 1, 2009
Sales and Marketing Cerezyme, Gaucher, Shire

 Shire has followed up its marketing applications for Gaucher disease treatment velaglucerase alfa in the US and Canada with a …

News

Shire goes for early approval in Gaucher disease

September 1, 2009
Research and Development, Sales and Marketing Gaucher's, Shire

Shire has filed for early US approval of its Gaucher disease drug velaglucerase alfa, as supplies to Genzyme's established rival …

News

Shire to close small molecule plant

April 14, 2009
Manufacturing and Production Shire

Shire Pharmaceuticals is shutting down a US production facility and will outsource the production to contract manufacturers DSM.The measure is …

News

Shire withdraws ADHD patch filing

March 19, 2009
Research and Development, Sales and Marketing Shire

Shire has withdrawn the European marketing application for its Attention Deficit Hyperactivity Disorder (ADHD) patch product Daytrana. The product's active …

News

Shire acquires ADHD presence in Europe

February 23, 2009
Sales and Marketing ADHD, Shire

Shire has bought the global rights for two established treatments for Attention Deficit Hyperactivity Disorder from UCB. The acquisition gives …

News
The Gateway to Local Adoption Series

Latest content

Closing the immunisation gap: partnership working that delivered at scale

June 3, 2026

China approves fruquintinib combination for kidney cancer

May 29, 2026

BIOTRONIK, Charité and GHCF launch digital cardiology partnership

May 28, 2026

Endometriosis study begins recruitment in UK hospitals

May 28, 2026

MHRA authorises donidalorsen for hereditary angioedema prevention

May 27, 2026